Advertisement

Gene transfer of protective cytokines in rheumatoid arthritis

  • Oliver Distler
  • Christiana Seemayer
  • Thomas Pap
  • Renate E. Gay
  • Michel Neidhart
  • Ulf Müller-Ladner
  • Steffen Gay
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 495)

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease primarily affecting the joints resulting in their progressive destruction and in significant morbidity in the individual patient. Although the course of the disease is variable, the cumulative prevalence of work disability is as high as 50% at 10 years after onset of the disease (1). Considering that the prevalence of rheumatoid arthritis among adults has recently been estimated to be 10 per 1000 in the US, and that rheumatoid arthritis affects patients often in their most productive years, the socio-economic consequences for both the individual patient and society are severe (2).

Keywords

Rheumatoid Arthritis Synovial Fibroblast Cartilage Degradation Human Cartilage Rheumatoid Arthritis Synovial Fibroblast 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    T.Sokka, H.Kautiainen, T.Mottonen, and P.Hannonen, Work disability in rheumatoid arthritis 10 years after the diagnosis, J Rheumatol. 26:1681 (1999).PubMedGoogle Scholar
  2. 2.
    R.C.Lawrence, C.G.Helmick, F.C.Arnett, R.A.Deyo, D.T.Felson, E.H.Giannini, S.P.Heyse, R.Hirsch, M.C.Hochberg, G.G.Hunder, M.H.Liang, S.R.Pillemer, V.D.Steen, and F. Wolfe, Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States, Arthritis Rheum. 41:778 (1998).PubMedCrossRefGoogle Scholar
  3. 3.
    C.M.Weyand, New insights into the pathogenesis of rheumatoid arthritis, Rheumatology.(Oxford) 39 Suppl 1:3 (2000).CrossRefGoogle Scholar
  4. 4.
    G.S.Firestein, Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?, Arthritis Rheum. 39:1781 (1996).PubMedCrossRefGoogle Scholar
  5. 5.
    K.M.Hummel, P.K.Petrow, J.K.Franz, U.Muller-Ladner, W.K.Aicher, R.E.Gay, D.Bromme, and S.Gay, Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction, J Rheumatol. 25:1887 (1998).PubMedGoogle Scholar
  6. 6.
    T.Pap, Y.Shigeyama, S.Kuchen, J.K.Fernihough, B.Simmen, R.E.Gay, M.Billingham, and S.Gay, Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis, Arthritis Rheum. 43:1226 (2000).PubMedCrossRefGoogle Scholar
  7. 7.
    G.Cunnane, O.FitzGerald, K.M.Hummel, R.E.Gay, S.Gay, and B.Bresnihan, Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis, Rheumatology.(Oxford) 38:34 (1999).CrossRefGoogle Scholar
  8. 8.
    U.Muller-Ladner, J.Kriegsmann, B.N.Franklin, S.Matsumoto, T.Geiler, R.E.Gay, and S.Gay, Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice, Am J Pathol. 149:1607 (1996).PubMedGoogle Scholar
  9. 9.
    T.Geiler, J.Kriegsmann, G.M.Keyszer, R.E.Gay, and S.Gay, A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice, Arthritis Rheum. 37:1664 (1994).PubMedCrossRefGoogle Scholar
  10. 10.
    C.Q.Chu, M.Field, S.Allard, E.Abney, M.Feldmann, and R.N.Maini, Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair, Br.J Rheumatol. 31:653 (1992).PubMedCrossRefGoogle Scholar
  11. 11.
    B.Bresnihan and G.Cunnane, Interleukin-1 receptor antagonist, Rheum.Dis.Clin.North Am 24:615 (1998).PubMedCrossRefGoogle Scholar
  12. 12.
    C.A.Dinarello, Biologic basis for interleukin-1 in disease, Blood 87:2095 (1996).PubMedGoogle Scholar
  13. 13.
    B.A.Moore, S.Aznavoorian, J.A.Engler, and L.J.Windsor, Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts, Biochim.Biophys.Acta 1502:307 (2000).PubMedCrossRefGoogle Scholar
  14. 14.
    R.Horai, S.Saijo, H.Tanioka, S.Nakae, K.Sudo, A.Okahara, T.Ikuse, M.Asano, and Y.Iwakura, Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice, J Exp.Med. 191:313 (2000).PubMedCrossRefGoogle Scholar
  15. 15.
    U.Muller-Ladner, C.R.Roberts, B.N.Franklin, R.E.Gay, P.D.Robbins, C.H.Evans, and S.Gay, Human IL-1Ra gene transfer into human synovial fibroblasts ischondroprotective, J Immunol. 158:3492 (1997).PubMedGoogle Scholar
  16. 16.
    M.Neidhart, R.E.Gay, and S.Gay, Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts, Arthritis Rheum. 43:1719 (2000).PubMedCrossRefGoogle Scholar
  17. 17.
    T.Pap, W.H.van der Laan, K.R.Aupperle, R.E.Gay, J.H.Verheijen, G.S.Firestein, S.Gay, and M.Neidhart, Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis, Arthritis Rheum. 43:2531 (2000).PubMedCrossRefGoogle Scholar
  18. 18.
    C.Q.Chu, M.Field, M.Feldmann, and R.N.Maini, Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis, Arthritis Rheum. 34:1 125 (1991).Google Scholar
  19. 19.
    J.Keffer, L.Probert, H.Cazlaris, S.Georgopoulos, E.Kaslaris, D.Kioussis, and G.Kollias, Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis, EMBO J 10:4025 (1991).Google Scholar
  20. 20.
    L.A.Joosten, M.M.Helsen, F.A.van De Loo, and W.B.van Den Berg, Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra, Arthritis Rheum. 39:797 (1996).PubMedCrossRefGoogle Scholar
  21. 21.
    A.F.Kavanaugh, Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis, Rheum.Dis.Clin.North Am 24:593 (1998).PubMedCrossRefGoogle Scholar
  22. 22.
    M.Grell, H.Wajant, G.Zimmermann, and P.Scheurich, The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor, Proc.Natl.Acad.Sci.U.S.A 95:570 (1998).PubMedCrossRefGoogle Scholar
  23. 23.
    B.W.Deleuran, C.Q.Chu, M.Field, F.M.Brennan, T.Mitchell, M.Feldmann, and R.N.Maini, Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha, Arthritis Rheum. 35:1170 (1992).PubMedCrossRefGoogle Scholar
  24. 24.
    F.M.Brennan, D.L.Gibbons, A.P.Cope, P.Katsikis, R.N.Maini, and M.Feldmann, TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action, Scand.J Immunol. 42:158 (1995).PubMedCrossRefGoogle Scholar
  25. 25.
    U.Muller-Ladner, C.H.Evans, B.N.Franklin, C.R.Roberts, R.E.Gay, P.D.Robbins, and S.Gay, Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model, Arthritis Rheum. 42:490 (1999).PubMedCrossRefGoogle Scholar
  26. 26.
    D.M.Butler, M.Feldmann, F.Di Padova, and F.M.Brennan, p55 and p’75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts, Eur.Cytokine Netw. 5:441 (1994).PubMedGoogle Scholar
  27. 27.
    L.A.Joosten, M.M.Helsen, T.Saxne, F.A.van De Loo, D.Heinegard, and W.B.van Den Berg, IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation, J Immunol. 163:5049 (1999).Google Scholar
  28. 28.
    E.Keystone, J.Wherry, and P.Grint, IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis, Rheum.Dis.Clin.North Am 24:629 (1998).PubMedCrossRefGoogle Scholar
  29. 29.
    C.Jorgensen, F.Apparailly, F.Canovas, C.Verwaerde, C.Auriault, C.Jacquet, and J.Sany, Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice, Arthritis Rheum. 42:678 (1999).PubMedCrossRefGoogle Scholar
  30. 30.
    M.E.Stearns, F.U.Garcia, K.Fudge, J.Rhim, and M.Wang, Role of interleukin 10 and transforming growth factor betal in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice, Clin.Cancer Res. 5:711 (1999).PubMedGoogle Scholar
  31. 31.
    E.Neumann, M.Judex, T.Pap, O.Distler, R.E.Gay, P.D.Robbins, C.H.Evans, J.Schölmerich, S.Gay, and U.Muller-Ladner, Additive cartilage protection by retrovirus-based double gene transfer with IL-1ra and IL-10 in the SCID mouse model for RA, Arthritis Rheum. 43:S170 (2000).Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Oliver Distler
    • 1
  • Christiana Seemayer
    • 1
  • Thomas Pap
    • 1
  • Renate E. Gay
    • 1
  • Michel Neidhart
    • 1
  • Ulf Müller-Ladner
    • 2
  • Steffen Gay
    • 1
  1. 1.WHO Collaborating Center for Molecular Biology and Novel Therapeutic Strategies for Rheumatic DiseasesUniversity Hospital ZurichSwitzerland
  2. 2.Department of Internal Medicine IUniversity of RegensburgGermany

Personalised recommendations